体外诊断试剂IVD欧盟EN13612性能评估部分中英文.docx

上传人:b****5 文档编号:12224291 上传时间:2023-04-17 格式:DOCX 页数:14 大小:21.78KB
下载 相关 举报
体外诊断试剂IVD欧盟EN13612性能评估部分中英文.docx_第1页
第1页 / 共14页
体外诊断试剂IVD欧盟EN13612性能评估部分中英文.docx_第2页
第2页 / 共14页
体外诊断试剂IVD欧盟EN13612性能评估部分中英文.docx_第3页
第3页 / 共14页
体外诊断试剂IVD欧盟EN13612性能评估部分中英文.docx_第4页
第4页 / 共14页
体外诊断试剂IVD欧盟EN13612性能评估部分中英文.docx_第5页
第5页 / 共14页
点击查看更多>>
下载资源
资源描述

体外诊断试剂IVD欧盟EN13612性能评估部分中英文.docx

《体外诊断试剂IVD欧盟EN13612性能评估部分中英文.docx》由会员分享,可在线阅读,更多相关《体外诊断试剂IVD欧盟EN13612性能评估部分中英文.docx(14页珍藏版)》请在冰豆网上搜索。

体外诊断试剂IVD欧盟EN13612性能评估部分中英文.docx

体外诊断试剂IVD欧盟EN13612性能评估部分中英文

3Generalrequirementsfortheperformanceevaluation

3.1Responsibilitiesandresources

Themanufacturertakestheresponsibilityfortheinitiationand/ortheconductofaperformanceevaluationstudy.Heshalldefinetheresponsibilityandtheinterrelationofallpersonnelwhomanage

andconducttheperformanceevaluationofIVDMDs,particularlyforpersonnelwhoneedthe

organisationalfreedomandauthorityto

a)assessthevalidityoftestresultsanddataalreadyavailable;

b)specifyperformanceclaimswhichshallbefurtherexaminedorconfirmed;

c)specifyanddocumenttheevaluationplanandthetestprocedures;

d)preparetheevaluationreport.

Themanufacturershallappointaco-ordinatorwithoverallresponsibilityoftheperformanceevaluation

study.Theco-ordinatorshallhimselfassurethatadequateresourcesareavailable.Theinvestigator

shallensurethattheevaluationplanisfollowedathislocationandthatthestudyisappropriately

reviewedfromanethicalpointofview.

3.2Documentation

Thedocumentationoftheperformanceevaluationstudyshallcontainthefilesrelatingtoclauses3to

7ofthisstandardandshallbepartofthetechnicaldocumentationoftheIVDMD.

3.3Finalassessmentandreview

Theco-ordinatorshallassessanddocumentwhichperformanceclaimsaremet,statewhetherclaims

arenotmetandgiverecommendationsforcorrectiveactions,wherenecessary.

Theresponsiblemanagementofthemanufacturershallmakesurethattheresultsoftheperformance

evaluationstudyandtherecommendationsforcorrectiveactionsarecarefullyconsideredandproperly

documentedbeforeissuingadeclarationofconformity.

4Organisationofaperformanceevaluationstudy

4.1Preconditions

Beforestartingaperformanceevaluationstudyitshallbeensuredbytheco-ordinatorthat

a)theperformanceclaimsoftheIVDMDwhicharethesubjectofthestudyarespecified;

b)theIVDMDhasbeenmanufacturedundercontrolledproductionprocessesandconditions;

c)theIVDMDtobeevaluatedmeetsthequalitycontrolreleasespecifications;

d)asufficientnumberofsamplesoftheIVDMDcanbeprovidedduringtheentireperiodofthe

performanceevaluationstudy;

e)alllegalrequirementsforperformanceevaluationstudiesaremet;

f)theinvestigator(s)is(are)adequatelyskilledandtrainedtoconductthestudyandthenecessary

resourcesareavailable.

4.2Evaluationplan

Theevaluationplanshallstatethepurposeonscientific,technicalormedicalgrounds,thescopeof

theevaluation,thestructureandorganizationofthestudyandthenumberofdevicesconcerned.

Definingtheobjectiveofthestudy,theco-ordinatorshallhaveassessedwhichperformanceclaims

arealreadyverifiedbydataorscientificliterature.

Theevaluationplanshallbedesignedtominimisetherequirementsforinvasivesampling.Inthecase

ofIVDMDsforself-testingitshallbeensuredthattheevaluationplanisappropriateandacceptableto

usersandtheinformationprovidedshallbeclearandeasilyunderstood.

Theevaluationplanshallspecify

a)thattheinvestigator(s)is(are)adequatelyskilledandtrainedtousetheIVDMD;

b)thelistoflaboratoriesorotherinstitutionstakingpartintheperformanceevaluationstudy;forselftesting,

thelocationandnumberoflaypersonsinvolved;

c)thetime-table;

d)thenecessaryminimumnumberofprobandsfromwhomspecimensarecollectedbyinvasive

proceduresinordertoadequatelyassesstheperformanceoftheIVDMD;

e)instructionsforuseincludingadescriptionoftheconditionsofuse;

f)theperformanceclaims(e.g.analyticalsensitivity,diagnosticsensitivity,analyticalspecificity,

diagnosticspecificity,accuracy,repeatability,reproducibility)tobevalidated;

g)theformatofperformancestudyrecords.

4.3Sitesandresources

Ingeneral,theperformancestudyprocedure(s)shallbecarriedoutunderconditionsreflectingthe

relevantintendedconditionsofuse.

Theco-ordinatorshalltaketheresponsibilityfortheproperconductoftheperformanceevaluation

studyatallsites.Allinvestigatorsshallbenamed.

Theco-ordinatorshallensureadequatecompetenceandskillatallsitesinvolvedandthatthe

necessaryresourcesareavailable.

WherelaypersonsareinvolvedinaperformanceevaluationstudyofanIVDMDforself-testing,the

locationofthestudyandthenumberofpersonsshallbegiven.Theco-ordinatorshallspecifythe

criteriafortheselectionofarepresentativepanel.

Especiallyforstudiesinvolvinglaypersonsitshallbeensuredthatthesepersonsdonotreceive

additionalinformationontheuseoftheIVDMDapartfromthatwhichisprovidedwiththeIVDMD

whenitisplacedonthemarketbecausethecomprehensionofthemanufacturer'sinstructionsforuse

isoneoftheimportantaspectsofthestudy.ltshallalsobeensuredthattheuntrainedperson(s)do

notreceiveanyadditionalinformationorhelp,e.g.fromatutor,otherthanthetrainingspecifiedand

providedbythemanufacturerintheinstructionsforuse.

4.4Basicdesigninformation

Theco-ordinatorshallprovidetheinvestigator(s)withsufficientinformationinordertounderstandthe

functionandapplicationoftheIVDMDand,wherenecessary,theinvestigatorshallmakehimself

familiarwiththeIVDMDanditsapplication.Theinformationprovidedshallincludeastatementthat

thedeviceinquestionconformswiththerequirementsoftheDirective98/79/ECapartfromthosetobe

evaluated.

4.5Experimentaldesign

Theexperimentalprocedurestovalidateeachperformanceclaimsubjecttotheperformance

evaluationstudyshallbedocumentedintheevaluationplan.

Specialconsiderationinperformanceevaluationstudiesofreagents/kitsshallbegiven,where

applicable,tothefollowing:

–specificationoftype(e.g.serum,plasma,urine)andproperties(e.g.concentrationrange,age

andsexoftheprobandpopulation)ofspecimensappropriatetotheintendeduse;

–probandstobeenrolled;

–suitability,stabilityandvolumeofspecimensandspecimenexclusioncriteria;

–blindprocedures,wherenecessary;

–reagentstability;

–inclusionofcommoninterferingfactors,causedbyspecimenconditionorthe

pathological/physiologicalstatusofthespecimendonorortreatment;

–conditionsforusewhichcanbereasonablyanticipated;specialattentionshallbepaidtothe

conditionsofusebylaypersons;

–selectionofanappropriatereferencemeasurementprocedureandreferencematerialof

higherorder,whereavailable;

–determinationofthestatusofspecimens(forqualitativetestswithanominalorordinalscale);

–calibrationprocedures,includingtraceability,whereappropriate;

–appropriatemeansofcontrol;

–limitationsofthetest;

–criteriaforre-examinationanddataexclusion;

–availabilityofadditionalinformationconcerningthespecimenordonoriffollow-upof

unexpectedresultsisrequired;

–appropriatemeasurestoreduceriskofinfectiontotheuser.

Wherethestudyisintendedtovalidatetheperformanceclaimsofaninstrumentspecialconsideration

shallbegivenadditionallytothefollowing:

–maintenanceandcleaning;

–carry-overeffects;

–softwarevalidation.

NOTEFortheinvestigationofthetechnicalaspectsofinstruments,otherstandardscanberelevant.

4.6Performancestudyrecords

Theperformancestudyrecordsshall

–refertotheexperimentalproceduresintheevaluationplan;

–beunequivocallyidentifiable;

–containorrefertoallresultsandrelatedrelevantdata;

–bepartofthetechnicaldocumentationoftheIVDMD.

Theprotectionofallconfidentialdatashallbeensured.

4.7Observationsandunexpectedoutcomes

Specialattentionshallbepaidtoobservationsandunexpectedoutcomes,e.g.dropouts,outliers,

instabilityofsampleorreagentsignaletc.,non-reproducibility,non-correlationofresultstothe

referenceortothediagnosticpattern,defectsorbreakdowns,softwareerrors,orerrorsignals.

Anydeviationfromthedefinedproceduresshallberecorded.InthecaseofIVDMDsforself-testing,

theinvestigatorortutorshalldulynoteanydifficultyorquestionausermayhaveandanydeviation

fromthemodeofapplicationoftheIVDMDasdescribedbythemanufacturer.

Anysuchobservationshallbeproperlyrecorded.Theco-ordinatorshall,togetherwiththeinvestigator,

tracethecausewheneverpossible.Theresultshallberecordedandshallbepartoftheevaluation

report.

Wherethevalidityoftheexaminationsalreadyperformedmaybequestionablebecauseofan

identifiedsourceoferrorthetestsshallberepeatedafterexclusionofthatcause.

Whereamisuseormisinterpretationoftheinstructionsforusehasbeenthecauseandwherean

unexpectedriskinherenttotheproductdesignorthemodeofapplicationhasbeenidentifiedthisshall

beclearlystated.

Theproposalsoftheinvestigator(s)andtheco-ordinatorforanyimprovementoftheIVDMDand/orits

applicationshallberecorded.

4.8Evaluationreport

Theco-ordinatorshallestablishanevaluationreport.Itshallcontainadescriptionofthestudy,an

analysisoftheresultstogetherwithaconclusionontheperformanceclaimsinvestigated.

Thereportshallalsodiscussanyunexpectedoutcomeswhichhaveoccurred.Itshallidentifythe

causewheneverpossibleandgiverecommendationsforcorrectiveactionstobetaken,where

necessary.

IfseveralstudieshavebeenconductedforoneIVDMD,asinglesummarizingreportmaybe

established.

5Modificationsduringtheperformanceevaluationstudy

Wherethemanufacturingprocesshasbeenchangeditshallbecheckedwhethertheperformance

claimsoftheIVDMDstillconformtothosewhichhadbeensetinitiall

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 表格模板 > 合同协议

copyright@ 2008-2022 冰豆网网站版权所有

经营许可证编号:鄂ICP备2022015515号-1